Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Prices
Pharma
AstraZeneca caps out-of-pocket inhaler costs at $35 in the US
At a critical moment for the U.S. inhaler market, AstraZeneca is following its peer Boehringer Ingelheim and taking a step to boost patient access.
Fraiser Kansteiner
Mar 18, 2024 11:02am
PhRMA seeks to revive IRA lawsuit, blasts Biden's SOTU update
Mar 8, 2024 8:57am
Boehringer cuts out-of-pocket inhaler prices to $35 in US
Mar 7, 2024 11:10am
GSK's asthma inhaler market pull draws Warren's ire
Mar 5, 2024 10:57am
Lawmakers blast Biden administration's 'march-in' proposal
Feb 23, 2024 9:53am
PhRMA taps Gilead CEO Dan O'Day as its new board chair
Feb 21, 2024 2:51pm